# WonderLab

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/wonderlab

- Industry: Healthcare Specialists
- Headquarters: Beijing, China
- Website: www.wangli-tech.com
- Latest round: Series B (Mar 2, 2026)
- Investors on record: 5

## About

Based in Beijing, China and founded in 2017, Adai Technology (Beijing) Co., Ltd., trading as WonderLab, is a digital medical service provider that focuses on the digital therapy of mental diseases. It has cooperated with three domestic mental illness medical institutions, including The Second Xiangya Hospital of Central South University, The Sixth Hospital of Peking University, and The Shanghai Mental Health Center. And its team members graduated from domestic and overseas universities, such as Peking University, Tsinghua University, New York University, and Columbia University. Moreover, its product, indications for cognitive impairment, received digital therapy registration certification. In March 2026, WonderLab closed Series B+ funding from Marathon Venture Partners.
The company has a self-developed platform for digital therapy of mental illness. The platform helps treat mental illnesses and improve mental health through artificial intelligence technology, and physiological data. Besides, the platform provides digital therapy for mental illnesses of depression, addiction, sleep problems, Alzheimer's, cognitive impairment, anxiety, and autism. It also developed applications for patients and administrators. And the platform has accumulated more than tens of thousands of patient data for electrophysiology, behavior, and medical diagnosis, which enables improved accuracy of the model.
The company generates revenue through providing a self-developed platform for digital therapy of mental illness.
The Series B+ funding raised in March 2026 will primarily be used for product research and development.

## Funding rounds

- Series B, Mar 2, 2026 — Marathon Venture Partners
- Series B, Oct 13, 2025 — Marathon Venture Partners
- Series A, Aug 30, 2021 — SIG Asia Investment, Wenzhou Kangning Hospital Group, Long Hill Capital, BioTrack Capital
- Series A, Feb 1, 2021 — SIG Asia Investment

## Investors

- SIG Asia Investment (https://capitalatlas.ai/funds/sig-asia-investment) — Series A
- Wenzhou Kangning Hospital Group — Series A
- Long Hill Capital (https://capitalatlas.ai/funds/long-hill-capital) — Series A
- BioTrack Capital (https://capitalatlas.ai/funds/biotrack-capital) — Series A
- Marathon Venture Partners (https://capitalatlas.ai/funds/marathon-venture-partners) — Series B